1. Home
  2. SGHT vs XRX Comparison

SGHT vs XRX Comparison

Compare SGHT & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.30

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Xerox Holdings Corporation

XRX

Xerox Holdings Corporation

HOLD

Current Price

$2.73

Market Cap

368.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
XRX
Founded
2011
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
368.8M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SGHT
XRX
Price
$5.30
$2.73
Analyst Decision
Buy
Hold
Analyst Count
7
1
Target Price
$9.08
$2.50
AVG Volume (30 Days)
197.8K
3.5M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
6.31%
EPS Growth
28.16
23.26
EPS
N/A
N/A
Revenue
$77,363,000.00
$117,000,000.00
Revenue This Year
$11.67
$8.96
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.11
$1.19
52 Week High
$9.24
$6.80

Technical Indicators

Market Signals
Indicator
SGHT
XRX
Relative Strength Index (RSI) 53.94 41.76
Support Level $4.76 $2.26
Resistance Level $5.74 $2.89
Average True Range (ATR) 0.35 0.23
MACD -0.04 -0.07
Stochastic Oscillator 38.80 15.38

Price Performance

Historical Comparison
SGHT
XRX

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About XRX Xerox Holdings Corporation

Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.

Share on Social Networks: